on long-term loyalty. Maximize Impact: Use CRM and marketing automation tools to deliver targeted, data-backed communication... effectively. What You’ll Bring Experience: 4+ years of relevant work experience in Growth Marketing and CRM/Lifecycle...
PIN-UP.CRM es un grupo de empresas que construyen un nivel de servicio y marketing de alta calidad... para todos los clientes del ecosistema. PIN-UP.CRM combina centros de llamadas, marketing de retención y SMM y ha operado con éxito desde 2018...
responsable de atender y gestionar los leads generados, utilizando un CRM y un sistema de seguimiento de clientes para optimizar..., gestionando su seguimiento en el CRM. - Utilizar manuales y procesos predefinidos para llevar a cabo tus funciones de manera...
. Disponibilidad completa. Manejo de Excel básico / CRM. ¿CUÁLES SERÁN TUS FUNCIONES? Realizar atención al cliente a través... de llamadas y correos Registro CRM. Cumplimiento de objetivos diarios. ¿QUÉ OFRECEMOS? Sueldo acorde al mercado Pago...
Chile, home to the world’s biggest lithium reserves, is confident that investors will compete for licenses to drill new deposits even amid a worsening global glut that’s squeezing the battery-metal industry. Continue Reading »
Gold Prices Today: Gold of 99.9 and 99.5 per cent purity grew ₹2,320 each in the last seven trading sessions. However, silver prices declined ₹500 to ₹93,500 per kg from the previous close Continue Reading »
At 11:57 a.m. ET, the Dow Jones Industrial Average rose 0.58 per cent, the S&P 500 gained 0.14 per cent, the Nasdaq Composite lost 0.19 per cent Continue Reading »
Expert view: Mohit Khanna anticipates the Union Budget 2025 will prioritize youth, women, the poor, and farmers, with increased spending on rural housing, irrigation, and employment-linked incentives. Continue Reading »
HPCL Q3 Results: The state-owned OMC's revenue from operations in the third quarter of current fiscal rose to ₹1.10 lakh crore led by better marketing margins. Continue Reading »
Dr Reddy's Laboratories reported a 2% YoY increase in PAT to ₹1,413.3 crore for Q3 2024, driven by a 16% rise in revenue to ₹8,358.6 crore. The company invested ₹6.7 billion in R&D, focusing on complex generics and biosimilars. Continue Reading »